tirzepatide lancet Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial The promise of tirzepatide: A

finally, combining molecular docking techniques to validate the binding modes of drugs and targets, and further evaluating the efficacy and safety of drugs via in vitro cell experiments and in vivo animal experiments (Gogoi and Saikia, 2022

The effects of gut microbiota in CHD are due to alterations in their composition and metabolites

Risk of Thyroid C-Cell Tumours: In studies with rodents, semaglutide caused thyroid C-cell tumours

Tesamorelin and the visceral-fat problem Tesamorelin is one of the most relevant therapies in body recomposition when central fat and visceral adiposity are a major part of the problem

This color deserves attention when it does not improve quickly

One of the main goal in caring for menopausal women is reducing cardiovascular risk